Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Robert Roman Lorenz, MD, MBA, FACS, is a surgeon in the Head and Neck Surgery Section of the Head and Neck Institute. He is board-certified in otolaryngology, head and neck surgery. In addition to his clinical practice, Dr. Lorenz also currently serves as the Medical Director of Payment Reform, Risk & Contracting for the Cleveland Clinic Health System. From 2008 to 2011, Dr. Lorenz served as the Chief Medical Officer of Cleveland Clinic Abu Dhabi (CCAD).
Dr. Lorenz's education includes a Bachelor of Science from Yale University and a Medical Doctorate with Honors from the University of Rochester School of Medicine, where he was inducted into the Alpha Omega Alpha Honor Medical Society. His training in otolaryngology, head and neck surgery was completed at the Cleveland Clinic, including an additional year of research. His fellowship was performed at Vanderbilt University in head and neck tumor and skull-base surgery. Dr. Lorenz returned to the Cleveland Clinic and became the Head of the Section of Head and Neck Surgery after one year of practice. His interests include airway reconstruction, head and neck tumors including paragangliomas, salivary gland neoplasms, carotid body tumors and Zenker’s diverticulum. He is an innovator in vocal cord paralysis, laryngeal and tracheal stenosis, as well as laryngeal and tracheal transplantation.
Dr. Lorenz has co-authored over 60 scientific articles, 12 book chapters and delivered over 140 invited national and international lectures or papers. Dr. Lorenz is an educator, teaching residents and fellows in head and neck surgery, and serves on the editorial board or as a reviewer for 10 different scientific journals in his field. He received his Masters of Business Administration with distinction from the London Business School in 2010.
airway stenosis, head and neck paraganglioma, Head And Neck Tumors including salivary gland neoplasms, larynx and tracheal reconstruction, skull base neoplasms, tracheotomy, vocal cord diseases, Vocal Cord Paralysis
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/22/2015, Dr. Lorenz has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.